Biomaterials Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

Rising Incidence of Cardiovascular Disorders Drives Demand for Biomaterials

Technological Advancements Enhance Biomaterial Variety and Applications

North America Expected to Dominate the Market with Supportive Initiatives

The global biomaterials market, valued at US$ 160 billion in 2024, is on track for substantial growth, projected to reach US$ 455 billion by 2031.

Market Overview

Biomaterials, which can be synthetic or natural, play a vital role in medical applications by replacing or enhancing organs, tissues, or body functions. Biomaterials science combines elements of biology, medicine, chemistry, and tissue engineering to create materials used in various healthcare applications.

Demand Drivers for Biomaterials

Rising Incidence of Cardiovascular Disorders: Cardiovascular diseases, fueled by factors like smoking, high blood pressure, and inactivity, have witnessed a surge in cases globally. Biomaterials, including heart valves, stents, and pacemakers, play a crucial role in the treatment of heart-related conditions. The World Health Organization reports a significant number of deaths annually due to cardiovascular diseases, highlighting the need for biomaterial-based solutions.
Technological Advancements: Ongoing technological innovations have expanded the range of biomaterials and their applications. Smart biomaterials, capable of interacting with biological systems, offer promising prospects for various biomedical applications, including drug delivery and tissue engineering.

Regional Insights

North America: Expected to dominate the global biomaterials market throughout the forecast period, North America boasts a robust healthcare infrastructure and supportive private and public initiatives. The region is a hub for research in gene therapies, vaccine development, and other medical advancements. Favorable government regulations and the presence of prominent market players contribute to market growth.
Asia Pacific: Following North America, Asia Pacific is poised for significant growth in the biomaterials market. Factors such as an aging population and an increasing incidence of bone fractures have led to growing adoption and installation of biomaterials. India, in particular, is expected to witness rapid expansion in the biomaterials market, with orthopedic, cardiovascular, and dental biomaterials leading the way.

Market Developments

Leading players in the biomaterials market are focusing on strategic collaborations, research and development activities, and expansion to enhance their product portfolios. Collaborations between key firms aim to develop innovative biomaterial-based implants and combination devices, providing a competitive edge and driving market growth.

Key Companies Profiled

Skan AG
COMECER S.p.A
Hosokawa Micron Ltd
Getinge AB
Azbil Telstar
Robert Bosch GmbH
Klenzaids
Nuaire
Iso Tech Design
M. BRAUN INERTGAS-SYSTEME GMBH
I.M.A. SpA
Syntegon Technologies GmbH
Esco Micro Pte. Ltd.

Biomaterials Industry Research Segmentation

By Material:

Metallic Biomaterials
Ceramic Biomaterials
Polymeric Biomaterials
Natural Biomaterials

By Application:

Dental
Cardiovascular
Orthopedic
Wound Healing
Neurology
Surgery

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Biomaterials Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Biomaterials Market Outlook, 2018 - 2031

3.1. Global Biomaterials Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Metallic Biomaterials
  - 3.1.1.2. Ceramic Biomaterials
  - 3.1.1.3. Polymeric Biomaterials
  - 3.1.1.4. Natural Biomaterials
3.2. Global Biomaterials Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Dental
  - 3.2.1.2. Cardiovascular
  - 3.2.1.3. Orthopedic
  - 3.2.1.4. Wound Healing
  - 3.2.1.5. Neurology
  - 3.2.1.6. Surgery
3.3. Global Biomaterials Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Biomaterials Market Outlook, 2018 - 2031

4.1. North America Biomaterials Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Metallic Biomaterials
  - 4.1.1.2. Ceramic Biomaterials
  - 4.1.1.3. Polymeric Biomaterials
  - 4.1.1.4. Natural Biomaterials
4.2. North America Biomaterials Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Dental
  - 4.2.1.2. Cardiovascular
  - 4.2.1.3. Orthopedic
  - 4.2.1.4. Wound Healing
  - 4.2.1.5. Neurology
  - 4.2.1.6. Surgery
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Biomaterials Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Biomaterials Market Outlook, 2018 - 2031

5.1. Europe Biomaterials Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Metallic Biomaterials
  - 5.1.1.2. Ceramic Biomaterials
  - 5.1.1.3. Polymeric Biomaterials
  - 5.1.1.4. Natural Biomaterials
5.2. Europe Biomaterials Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Dental
  - 5.2.1.2. Cardiovascular
  - 5.2.1.3. Orthopedic
  - 5.2.1.4. Wound Healing
  - 5.2.1.5. Neurology
  - 5.2.1.6. Surgery
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Biomaterials Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Biomaterials Market Outlook, 2018 - 2031

6.1. Asia Pacific Biomaterials Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Metallic Biomaterials
  - 6.1.1.2. Ceramic Biomaterials
  - 6.1.1.3. Polymeric Biomaterials
  - 6.1.1.4. Natural Biomaterials
6.2. Asia Pacific Biomaterials Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Dental
  - 6.2.1.2. Cardiovascular
  - 6.2.1.3. Orthopedic
  - 6.2.1.4. Wound Healing
  - 6.2.1.5. Neurology
  - 6.2.1.6. Surgery
- 6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Biomaterials Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Biomaterials Market Outlook, 2018 - 2031

7.1. Latin America Biomaterials Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Metallic Biomaterials
  - 7.1.1.2. Ceramic Biomaterials
  - 7.1.1.3. Polymeric Biomaterials
  - 7.1.1.4. Natural Biomaterials
7.2. Latin America Biomaterials Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Dental
  - 7.2.1.2. Cardiovascular
  - 7.2.1.3. Orthopedic
  - 7.2.1.4. Wound Healing
  - 7.2.1.5. Neurology
  - 7.2.1.6. Surgery
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Biomaterials Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Biomaterials Market Outlook, 2018 - 2031

8.1. Middle East & Africa Biomaterials Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Metallic Biomaterials
  - 8.1.1.2. Ceramic Biomaterials
  - 8.1.1.3. Polymeric Biomaterials
  - 8.1.1.4. Natural Biomaterials
8.2. Middle East & Africa Biomaterials Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Dental
  - 8.2.1.2. Cardiovascular
  - 8.2.1.3. Orthopedic
  - 8.2.1.4. Wound Healing
  - 8.2.1.5. Neurology
  - 8.2.1.6. Surgery
8.3. Middle East & Africa Biomaterials Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa Biomaterials Market by Material, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Biomaterials Market by Application, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs by Application Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Evonik Industries AG
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Medtronic plc
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Carpenter Technology Corporation
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Invibio Ltd.
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Berkeley Advanced Biomaterials
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. BASF SE
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Zimmer Biomet Holdings, Inc
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Stryker
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Covalon Technologies Ltd.
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Johnson & Johnson
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations